Page last updated: 2024-08-16

mitomycin and 7-hydroxystaurosporine

mitomycin has been researched along with 7-hydroxystaurosporine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akinaga, S; Gomi, K; Nomura, K; Okabe, M	1
Saijo, N	1
Akinaga, S; Akiyama, T; Eastman, A; Shimizu, M; Sugiyama, K; Takahashi, R; Tamaoki, T; Yamaguchi, K	1

Reviews

1 review(s) available for mitomycin and 7-hydroxystaurosporine

Article	Year
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience. Chest, 1998, Volume: 113, Issue:1 Suppl Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	1998

Article

Year

New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.

Chest, 1998, Volume: 113, Issue:1 Suppl

Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

1998

Other Studies

2 other study(ies) available for mitomycin and 7-hydroxystaurosporine

Article	Year
Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:3 Topics: Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Drug Synergism; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Protein Kinase C; Staurosporine; Tumor Cells, Cultured	1993
UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation. International journal of cancer, 2000, Mar-01, Volume: 85, Issue:5 Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Drug Synergism; Female; G2 Phase; Genes, p53; Humans; In Situ Nick-End Labeling; Mitomycin; Protein Kinases; S Phase; Staurosporine; Tumor Cells, Cultured	2000

Article

Year

Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.

Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:3

Topics: Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Drug Synergism; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Protein Kinase C; Staurosporine; Tumor Cells, Cultured

1993

UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation.

International journal of cancer, 2000, Mar-01, Volume: 85, Issue:5

Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Cell Survival; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Drug Synergism; Female; G2 Phase; Genes, p53; Humans; In Situ Nick-End Labeling; Mitomycin; Protein Kinases; S Phase; Staurosporine; Tumor Cells, Cultured

2000